Greater emphasis on how pharmaceutical companies perform in access to medicine: methodology for the 2016 Access to Medicine Index

Amsterdam, the Netherlands, 30 October 2015: The Access to Medicine Index ranks the world’s leading pharmaceutical companies on their efforts to improve access to life-saving drugs, vaccines, diagnostic tests and other health technologies in developing countries. Today, the Access to Medicine Foundation publishes the methodology for the 2016 Index. It increases its emphasis on companies’ performances, and will use new metrics to track R&D and needs-based pricing strategies.

Get in touch

Back to top |